￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The listing status of Apelvis in China in 2024 and the latest information on medical insurance

2026-02-01 22:25:32

Check Details
Abolib (Apelis) inclusion in medical insurance in 2024

2026-02-01 22:25:32

Check Details
Guidelines for taking the breast cancer targeted drug Apelvis

2026-02-01 22:25:32

Check Details
Introduction to Apelis (Abolib) and applicable groups

2026-02-01 22:25:32

Check Details
Instructions for use of Indian version of Apelvis (Abolib)

2026-02-01 22:25:32

Check Details
Are the side effects of neratinib serious?

2026-02-01 22:25:32

Check Details
A guide to identifying the authenticity of the Bangladeshi version of Neratinib

2026-02-01 22:25:32

Check Details
2024 Neratinib (Neratinib) Drug Purchasing Guide

2026-02-01 22:25:32

Check Details
Neratinib (neratinib) applicable conditions and medication guidance

2026-02-01 22:25:32

Check Details
Medication warnings and contraindications for neratinib

2026-02-01 22:25:32

Check Details
Instructions for taking neratinib correctly

2026-02-01 22:25:32

Check Details
The cost of one year of treatment with neratinib

2026-02-01 22:25:32

Check Details
Category
相关知识